These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15018242)

  • 21. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis.
    Toya Y; Chiba T; Mizutani T; Sato K; Kasugai S; Matsuda N; Orikasa S; Shibata S; Abiko Y; Akasaka R; Yokoyama N; Oana S; Hirota S; Endo M; Suzuki K
    Cytokine; 2013 Apr; 62(1):146-50. PubMed ID: 23465691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis.
    Hashiguchi K; Takeshima F; Akazawa Y; Matsushima K; Minami H; Machida H; Yamaguchi N; Shiozawa K; Ohba K; Ohnita K; Ichikawa T; Isomoto H; Nakao K
    Digestion; 2015; 91(3):208-17. PubMed ID: 25823500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte and monocyte adsorptive apheresis induces apoptosis of neutrophils and release of a novel chemoattractant for desensitization of interleukin-8 response - In vitro and in vivo results.
    Kashiwagi N; Saito F; Maegawa H; Kaneda K
    Cytokine; 2021 Mar; 139():155410. PubMed ID: 33395614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.
    Löhr HF; Gerken G; Roth M; Weyer S; Schlaak JF; Meyer zum Büschenfelde KH
    J Hepatol; 1998 Oct; 29(4):524-32. PubMed ID: 9824260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis.
    Iwakami Y; Sakuraba A; Sato T; Takada Y; Izumiya M; Ichikawa H; Hibi T
    Ther Apher Dial; 2009 Apr; 13(2):138-46. PubMed ID: 19379153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis.
    Mizutani Y; Fujii K; Kawamura M; Inoue M; Mizutani YH; Matsuyama K; Doi T; Nagaya S; Seishima M
    J Dermatol; 2020 Nov; 47(11):1326-1329. PubMed ID: 32860246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
    Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
    BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study.
    Ueno N; Saito S; Sato M; Sugiyama Y; Kobayashi Y; Murakami Y; Sugimura K; Sasaki T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M
    Ther Apher Dial; 2024 Jun; 28(3):442-452. PubMed ID: 38168492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of hepatitis C virus load during hemodialysis: novel perspectives.
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(4):467-75. PubMed ID: 14696748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.
    Kikuyama R; Fukunaga K; Kawai M; Yokoyama Y; Kamikozuru K; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kato K; Kono T; Nogami K; Nagase K; Nakamura S; Takei Y; Miwa H; Matsumoto T
    Ther Apher Dial; 2011 Aug; 15(4):360-6. PubMed ID: 21884470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.
    Shiratori Y; Kato N; Yoshida H; Imazeki F; Okano K; Yokosuka O; Omata M
    J Gastroenterol Hepatol; 1999 Jan; 14(1):79-84. PubMed ID: 10029282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis.
    Fujisawa T; Tawada C; Mizutani Y; Doi T; Yoshida S; Ogura S; Seishima M
    Ther Apher Dial; 2014 Jun; 18(3):238-43. PubMed ID: 24965289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia.
    Marson P; Boschetto R; De Silvestro G; Martini S; Gabelli C; Buoro S; Giordano R; Palù G
    Int J Artif Organs; 1999 Sep; 22(9):640-4. PubMed ID: 10532434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases.
    Kato S; Kani K; Takabayashi H; Yamamoto R; Ogawa T; Matsuda A; Yakabi K
    Intern Med; 2011; 50(15):1591-3. PubMed ID: 21804287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral kinetics of hepatitis C virus RNA in patients with chronic hepatitis C treated with 18 MU of interferon alpha daily.
    Sentjens RE; Weegink CJ; Beld MG; Cooreman MC; Reesink HW
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):833-40. PubMed ID: 12172402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow up of sustained viral response after treatment of hepatitis C with pegylated interferon alpha-2a in hemodialysis patients.
    Dzekova P; Asani A; Selim G; Gelev S; Trajceska L; Amitov V; Selja N; Zabzun M; Mena S; Gaseva M; Sikole A
    Int J Artif Organs; 2009 Mar; 32(3):180-4. PubMed ID: 19440994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.